M L 22 (Lisinopril 2.5 mg)
Pill imprint M L 22 has been identified as Lisinopril 2.5 mg.
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; heart attack; migraine prevention (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M L 22 (Lisinopril 2.5 mg)
- 2.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dihydrate dibasic
sodium lauryl sulfate
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|51079-0256||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
Lisinopril is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...